Drug discovery is a high-risk, high-reward field, where a blockbuster therapy can deliver life-changing clinical benefits to millions of patients and generate billions of dollars in profit—but more than 90% of new drug development efforts ultimately prove fruitless. PolarisQB is using quantum computing with AI and precision medicine to search chemical space and create novel molecular drugs for specific proteins and diseases much more quickly than using traditional methods. In order to find a new preclinical lead candidate, the first step is to build a library of small molecules that may interact with the target protein binding pocket. Traditionally, library design involves wet lab testing that takes years, costs millions, and is limited to a narrow chemical space. With the power of D-Wave’s quantum technology, PolarisQB finds optimized molecules in days from a highly diverse library of 10^30 possibilities. This size of the library is 20 orders of magnitude bigger than the current industry standard.